Literature DB >> 16091118

Extracellular matrix remodeling in oral submucous fibrosis: its stage-specific modes revealed by immunohistochemistry and in situ hybridization.

Hiroko Utsunomiya1, Wanninayake M Tilakaratne, Kazufumi Oshiro, Satoshi Maruyama, Makoto Suzuki, Hiroko Ida-Yonemochi, Jun Cheng, Takashi Saku.   

Abstract

BACKGROUND: Oral submucous fibrosis (OSF) is a chewing habit-related pre-cancerous condition of the oral mucosa affecting predominantly south Asians. It is histopathologically characterized by epithelial atrophy and fibrosis of the subepithelial connective tissue. Fibrosis extends all the way into the muscle layer, leading to difficulty in mouth opening. However, the dynamics of extracellular matrix (ECM) remodeling with OSF progression is largely unknown.
METHODS: Forty biopsy specimens of OSF and 10 of normal buccal mucosa were examined for expression/deposition modes of eight ECM molecules by histochemistry, immunohistochemistry, and in situ hybridization.
RESULTS: In the early stage of OSF, tenascin, perlecan, fibronectin, collagen type III were characteristically enhanced in the lamina propria and the submucosal layer. In the intermediate stage, the ECM molecules mentioned above and elastin were extensively and irregularly deposited around muscle fibers. In the advanced stage, such ECM depositions decreased and were entirely replaced with collagen type I only. Their gene expression levels varied with progression of fibrosis, but the mRNA signals were confirmed in fibroblasts in the submucosal fibrotic areas.
CONCLUSIONS: The results indicate that the ECM remodeling steps in OSF are similar to each phase of usual granulation tissue formation. Restricted mouth opening may be a result of loss of variety of ECM molecules including elastin into the homogeneity of collagen type I replacing muscle fibers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091118     DOI: 10.1111/j.1600-0714.2005.00339.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  32 in total

Review 1.  Hyperbaric Oxygen Therapy-A Novel Treatment Modality in Oral Submucous Fibrosis: A Review.

Authors:  M Ashwini Kumar; Besta Radhika; Nishanth Gollamudi; Satya Prakash Reddy; Uday Shankar Yaga
Journal:  J Clin Diagn Res       Date:  2015-05-01

Review 2.  Management of oral submucous fibrosis: an overview.

Authors:  Punnya V Angadi; Sanjay Rao
Journal:  Oral Maxillofac Surg       Date:  2010-09

3.  Treatment of oral submucous fibrosis using split skin graft and a polyethylene stent: a prospective study.

Authors:  Chen Loong Soh; M R Muthusekhar
Journal:  J Maxillofac Oral Surg       Date:  2014-08-13

4.  Perlecan-enriched intercellular space of junctional epithelium provides primary infrastructure for leukocyte migration through squamous epithelial cells.

Authors:  Satoshi Maruyama; Manami Itagaki; Hiroko Ida-Yonemochi; Takehiko Kubota; Manabu Yamazaki; Tatsuya Abé; Hiromasa Yoshie; Jun Cheng; Takashi Saku
Journal:  Histochem Cell Biol       Date:  2014-02-23       Impact factor: 4.304

5.  Tenascin-C in chronic sclerosing sialadenitis.

Authors:  Apostolos Epivatianos; Fotis Iordanidis; Dimitrios Andreadis; Savas Iordanidis; Athanasios Poulopoulos; Anastasios Markopoulos
Journal:  Head Neck Pathol       Date:  2011-05-11

6.  Evaluation of mast cells and burning sensation in various stages of Oral Submucous Fibrosis.

Authors:  Laliytha Bijai Kumar; Philips Mathew; Nirmal Madhavan; Sabin Siddique; Nandita Kshetrimayum; Kiran Iyer
Journal:  J Oral Biol Craniofac Res       Date:  2020-07-31

Review 7.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Tumours of the Oral Cavity and Mobile Tongue.

Authors:  Susan Muller; Wanninayake M Tilakaratne
Journal:  Head Neck Pathol       Date:  2022-03-21

8.  Clinical and histopathological evaluation of collagen fiber orientation in patients with oral submucous fibrosis.

Authors:  Br Smitha; Mandana Donoghue
Journal:  J Oral Maxillofac Pathol       Date:  2011-05

9.  Expression of Ki67 Biomarker in Oral Submucous Fibrosis with Clinico-Pathological Correlations: A Prospective Study.

Authors:  K A Kamala; Sujata R Kanetkar; Kailash D Datkhile; S Sankethguddad
Journal:  Asian Pac J Cancer Prev       Date:  2022-01-01

10.  Role of Areca Nut Induced TGF-β and Epithelial-Mesenchymal Interaction in the Pathogenesis of Oral Submucous Fibrosis.

Authors:  Ila Pant; Neeraj Kumar; Imran Khan; Somanahalli Girish Rao; Paturu Kondaiah
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.